{"pub": "morningstar", "url": "https://morningstar.com/news/dow-jones/2019091010822/health-care-up-slightly-after-price-control-plan-circulates-health-care-roundup", "downloaded_at": "2019-09-10 23:29:12.809203+00:00", "title": "Health Care up Slightly After Price Control Plan Circulates \u2014 Health Care Roundup", "language": "en", "text": "Health-care companies rose, but lagged other sectors, after the latest drug-price control plan circulated around Washington.\n\nAmong other proposals in a plan to lower prescription-drug prices from House Speaker Nancy Pelosi is a call for direct negotiations between the Department of Health and Human Services and manufacturers for the top 250 drugs sold in Medicare, The Wall Street Journal reported.\n\nMallinckrodt shares surged after it agreed to sell its contract drug-manufacturing subsidiary to private-equity firm H.I.G. Capital in a deal worth up to $250 million, taking some of the pressure off a company reeling from opioid-drug litigation.\n\nWrite to Rob Curran at rob.curran@dowjones.com\n\n(END) Dow Jones Newswires\n\nSeptember 10, 2019 17:11 ET (21:11 GMT)\n\nCopyright (c) 2019 Dow Jones & Company, Inc.", "description": "", "authors": [], "top_image": "https://morningstar.com/assets/img/30241a1.png", "published_at": "2019-09-10"}